Affiliation:
1. Shupyk National Medical Academy of Postgraduate Education
Abstract
The study of the concentration of metalloproteinases, pro- and anti-inflammatory cytokines, lymphocyte activation markers in seminal plasma of men with oligosymptomatic forms of chronic inflammation of the urogenital tract (CIUT), depending on the fertility rate are presented in the article.
Quantitative characteristics in male sperm with different forms of pathospermia were studied for matrix metalloproteinases (MMP) -2 and MMP-9 and their inhibitors - tissue inhibitors of metalloproteinases (TIMP)-1 and TIMP-2. It was shown, that during chronic inflammation of the urogenital tract of men are shifting levels of cytokine profile, reducing the concentration of metalloproteinase-2, chemokines - fractalkine and regulated by activation, expression and secretion of normal T-cells (RANTES), sharp increase in IL-8, MCP-1 and elevation of the CD25+ / CD95+, indicating that the disturbance of apoptosis of pathological forms generative cells and their accumulation in the sperm.
The ratio of immunological indices IL-2/IL-4, IL-10/IL-12 was calculated and a significant increase in the IL-10/IL-12 index was noted in the group of individuals with elevated levels of hypercapitated form of sperm, and a reduced proportion of this ratio was observed in the microsomatic morphology of sperm. Prolonged inflammation in the genital area accompanied by depletion of the local immune system, resulting in the development of infertility.
Immunocorrection therapy for men with CIUT should take into account the peculiarities of changes in local immunity and be differentiated depending on the prevalence of certain pathological forms of sperm and changes in the cytokine profile of the seminal plasma.
Reference26 articles.
1. Orlova, L., Pyetrov, S. (2011). Aktyvnist metaloproteinazy matryksu (ММР-2) I. Katepsynopodibnoyi proteyinazy D u riznych vydiv zmiy. Visnyk Lvivskogo Universytetu, 55, 34–38.
2. Syed, R., Farukh, R., Shaista, R., Akbar, M., Shajrul, A. (2012). Role of proteases in cancer: A review. Biotechnology and Molecular Biology Reviews, 7 (4), 90–101. doi: 10.5897/bmbr11.027
3. Radisky, E. S., Radisky, D. C. (2010). Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia, 15 (2), 201–212. doi: 10.1007/s10911-010-9177-x
4. Jablonska-Trypuc, A., Matejczyk, M., Rosochacki, S. (2016). Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. Journal of Enzyme Inhibition and Medicinal Chemistry, 31, 177–183. doi: 10.3109/14756366.2016.1161620
5. Lu, P., Takai, K., Weaver, V. M., Werb, Z. (2011). Extracellular Matrix Degradation and Remodeling in Development and Disease. Cold Spring Harbor Perspectives in Biology, 3 (12), a005058. doi: 10.1101/cshperspect.a005058